Lesley Portnoy and Karyopharm Therapeutics

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Karyopharm Therapeutics, Inc. | Globe Newswire | 9/16/2019

… the upcoming September 23, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Karyopharm Therapeutics, Inc. (“Karyopharm” or the “Company”) (NASDAQ: KPTI ) investors that: (1) purchased shares of … rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to [email protected] , or visit our website at www.glancylaw.com . On February 22, 2019 …

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Karyopharm Therapeutics, Inc. – Company Announcement - FT.com | Financial Times | 8/3/2019

… the upcoming September 23, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Karyopharm Therapeutics , Inc. (“Karyopharm” or the “Company”) (NASDAQ: KPTI ) investors that: (1) purchased shares of … rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire , at 310-201-9150, Toll-Free at 888-773-9224, or by email to [email protected] , or visit our website at www.glancylaw.com . On February 22, 2019 …

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Karyopharm Therapeutics, Inc. | Business Wire | 8/2/2019

… the upcoming September 23, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Karyopharm Therapeutics, Inc. (“Karyopharm” or the “Company”) (NASDAQ: KPTI ) investors that: (1) purchased shares of … rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to [email protected] , or visit our website at www.glancylaw.com . On February 22, 2019 …

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Karyopharm Therapeutics, Inc. Investors | Business Wire | 7/27/2019

… LLP (“GPM”), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of Karyopharm Therapeutics, Inc. (“Karyopharm” or the “Company”) (NASDAQ: KPTI ) investors that: (1) purchased shares of … rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to [email protected] , or visit our website at www.glancylaw.com . On February 22, 2019 …

Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action on Behalf of Karyopharm Therapeutics, Inc. Investors – Company Announcement - FT.com | Financial Times | 7/27/2019

… LLP (“GPM”), a national investors rights law firm, announces that a class action lawsuit has been filed on behalf of Karyopharm Therapeutics , Inc. (“Karyopharm” or the “Company”) (NASDAQ: KPTI ) investors that: (1) purchased shares of … rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire , at 310-201-9150, Toll-Free at 888-773-9224, or by email to [email protected] , or visit our website at www.glancylaw.com . On February 22, 2019 …

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Karyopharm Therapeutics, Inc. Investors (KPTI) | Business Wire | 7/26/2019

Karyopharm Therapeutics, Inc. (“Karyopharm” or the “Company”) (NASDAQ: KPTI ) investors concerning the Company and its officers’ possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150 …